OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
Milei Threatens Falkland Oil Firms With Sanctions 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Adobe Names Anil Chakravarthy CEO as AI Push Accelerates 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
Xiaomi Shares Jump on Europe EV Expansion Plan 
SEC Seeks ISS Client Voting Records in Proxy Adviser Probe 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
Anthropic IPO Marketing Expected to Start in Mid-October 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
Add as a preferred source on Google
CHICAGO, Feb. 20, 2018 -- Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the appointment of Scott A. Falk, MD, to the firm’s Physician Advisory Council.
A practicing anesthesiologist and critical care physician, Dr. Falk serves as Director of Performance Improvement, Quality and Safety at Penn Medicine (University of Pennsylvania). He is also an Associate Professor of Clinical Anesthesiology and Critical Care at the University of Pennsylvania. He brings a wealth of experience, including past positions as post-anesthesia care unit (PACU) and surgical intensive care unit (SICU) medical director, and years of experience improving healthcare value and outcomes.
“Our Physician Advisory Council uniquely enables us to foster alignment between physicians and hospital leaders with insights from practicing clinicians,” said Lumere CEO Hani Elias, JD, MPH. “With Dr. Falk’s background, we’re now able to provide even more in-depth guidance to our clients as they tackle issues related to device and drug selection for anesthesiology and critical care, two areas that offer significant opportunities.”
According to Dr. Falk, he’s eager to help Lumere’s clients optimize patient care. “Healthcare costs have been spiraling out of control for a number of years, partly due to the vast array of devices and therapies we have to choose from,” he said. “However, the reality is that patient outcomes have not improved at the same pace. Lumere allows physicians to work with their hospitals to refocus on providing the right solutions and making the best decisions about patient care.”
Dr. Falk joined the faculty of Penn Medicine in 2006. He received his medical degree from The George Washington University School of Medicine and Health Sciences and completed his fellowship with the Clinical Clinic Foundation.
About Lumere
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.
Media Contact
Pam Flores
[email protected]
(773) 218-9260
